Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01448733|
Recruitment Status : Unknown
Verified October 2011 by Joshua Zeichner, Zeichner, Joshua, M.D..
Recruitment status was: Active, not recruiting
First Posted : October 7, 2011
Last Update Posted : October 7, 2011
|Condition or disease||Intervention/treatment||Phase|
|Acne Vulgaris||Drug: Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Pilot Study to Evaluate the Safety and Tolerability of CeraVe® Lotion Followed by Fixed Dose Clindamycin Phosphate 1.2% / Benzoyl Peroxide 2.5% Gel in the Morning in Combination With CeraVe® Lotion Followed by Tretinoin 0.05% Gel in the Evening for the Treatment of Facial Acne Vulgaris.|
|Study Start Date :||July 2011|
|Estimated Primary Completion Date :||October 2011|
|Estimated Study Completion Date :||October 2011|
Experimental: Acanya Plus Atralin
A single, open-label arm treating acne with Cerave lotion plus Acanya gel in the morning in combination with Cerave lotion plus Atralin gel in the evening.
Drug: Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening
Green pea sized amount of Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning in combination with a green pea sized amount of tretinoin 0.05% gel in the evening
- Cutaneous Tolerability of Combination Therapy of Acanya Gel with Atralin Gel for the treatment of acne vulgaris [ Time Frame: 12 weeks ]Evaluation of skin erythema, scaling, drying, and stinging/burning
- Efficacy of Combination Therapy of Acanya Gel with Atralin Gel for the treatment of acne vulgaris [ Time Frame: 12 weeks ]Evaluation of efficacy as defined as a global assessment of clear or almost clear after 12 weeks of therapy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01448733
|United States, New York|
|Mt Sinai Hospital, Department of Dermatology|
|New York, New York, United States, 10029|